Biomea Fusion
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
BMEA Key Statistics
Stock Snapshot
The current Biomea Fusion(BMEA) stock price is $1.27, with a market capitalization of 89.79M. The stock trades at a price-to-earnings (P/E) ratio of -0.52.
As of 2026-02-13, Biomea Fusion(BMEA) stock has fluctuated between $1.25 and $1.29. The current price stands at $1.27, placing the stock +1.6% above today's low and -1.6% off the high.
The Biomea Fusion(BMEA)'s current trading volume is 153.68K, compared to an average daily volume of 1.2M.
In the last year, Biomea Fusion(BMEA) shares hit a 52-week high of $3.96 and a 52-week low of $0.87.
In the last year, Biomea Fusion(BMEA) shares hit a 52-week high of $3.96 and a 52-week low of $0.87.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.